Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Dec 12, 2016 $1.92 $1.96 $1.81 $1.89 83 341
Dec 09, 2016 $1.91 $1.97 $1.90 $1.94 53 464
Dec 08, 2016 $1.91 $1.97 $1.89 $1.91 95 214
Dec 07, 2016 $1.93 $1.97 $1.92 $1.96 119 902
Dec 06, 2016 $1.90 $2.01 $1.88 $1.92 74 065
Dec 05, 2016 $1.80 $1.90 $1.78 $1.88 133 215
Dec 02, 2016 $1.75 $1.81 $1.73 $1.79 82 754
Dec 01, 2016 $1.81 $1.84 $1.75 $1.75 131 948
Nov 30, 2016 $1.85 $1.85 $1.81 $1.81 91 407
Nov 29, 2016 $1.83 $1.88 $1.83 $1.86 60 703
Nov 28, 2016 $1.90 $1.99 $1.85 $1.85 70 707
Nov 25, 2016 $1.89 $1.94 $1.89 $1.93 59 269
Nov 23, 2016 $1.86 $1.90 $1.83 $1.89 45 026
Nov 22, 2016 $1.97 $2.00 $1.85 $1.87 68 494
Nov 21, 2016 $1.89 $2.00 $1.89 $1.96 126 728
Nov 18, 2016 $1.95 $1.99 $1.90 $1.90 139 342
Nov 17, 2016 $1.98 $2.02 $1.95 $1.96 188 894
Nov 16, 2016 $1.96 $2.05 $1.95 $2.00 164 683
Nov 15, 2016 $2.08 $2.10 $1.96 $2.00 148 081
Nov 14, 2016 $2.05 $2.09 $1.94 $2.09 259 586
Nov 11, 2016 $1.95 $2.05 $1.76 $2.05 440 734
Nov 10, 2016 $1.85 $1.92 $1.81 $1.90 413 299
Nov 09, 2016 $1.55 $1.83 $1.55 $1.67 536 750
Nov 08, 2016 $1.60 $1.60 $1.52 $1.56 94 691
Nov 07, 2016 $1.61 $1.62 $1.51 $1.57 129 200
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT